Trial Profile
A Phase 1 Study of the Safety and Pharmacokinetics (PK) of Levodopa Following Administration of CVT 301 (Levodopa Inhalation Powder) in Adults With Asthma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Apr 2017
Price :
$35
*
At a glance
- Drugs Levodopa (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Acorda Therapeutics
- 29 Mar 2017 Results published in an Acorda Therapeutics media release.
- 10 Jun 2016 Status changed from active, no longer recruiting to completed.
- 22 Apr 2016 Status changed from recruiting to active, no longer recruiting.